explore -WSS

explore

author：Wikipedia 2025-09-06 04:37:02 - browse：1

Sen. Bernie Sanders, I-Vt., chairman of the Senate Health, Education, Labor, and Pensions Committee listens during a hearing on Capitol Hill in Washington – politics and policy coverage from STAT — Senate health committee Chair Bernie Sanders (I-Vt.) wants to reward new medicines with prize money. Jose Luis Magana/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will finally get a study of his proposal to do away with drug patents and other intellectual property protections in favor of rewarding inventions with prize money. Sanders has been pushing the prize approach since he was a House representative, many years ago.

The measure directing the National Academies of Sciences, Engineering and Medicine to study the idea was added to the Pandemic All-Hazards and Preparedness Act a day before Sander’s health committee passed the bill. Three Republicans voted against the overall bill, which renews several federal biodefense and pandemic-preparedness programs.

Though Democrats last year passed historic legislation to let Medicare negotiate drug prices and cap seniors’ annual out-of-pocket drug costs, Sanders is demanding more drug price controls. He is delaying President Biden’s pick for running the National Institutes of Health until the president releases a plan to control drug prices.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Readout LOUD podcast: The Sarepta saga, decoding biotech hype

entertainment

WSS

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Covid vaccines: Private market messier than government rollout

Address the ethical violations that led to 'Three Identical Strangers'

Listen: Who gets the credit for GLP

Explaining an after

Brain injuries and the importance of a second opinion

explore

explore

entertainment

Jerome Adams on the need for new antivirals for Covid

Cigna to pay $172 million to settle Medicare Advantage fraud probe

At least 13 dead in Texas as scorching temps continue

Kaiser Permanente unions announce official strike date

As demand for Covid shots wanes, Moderna seeks its next success

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Duchenne breakthrough therapy leaves behind pioneering families

All of Us, NIH's precision medicine initiative, gets a big boost

Activists slam private health insurers over coverage restrictions

Life sciences investors close nearly $6 billion in new funds

explore

FDA seeks to regulate lab

Explaining an after

Ionis has late

Intercept Pharmaceuticals sells itself for less than $1 billion

Medicaid, Medicare dual

Address the ethical violations that led to 'Three Identical Strangers'

entertainment

entertainment

focus

Wikipedia